The Winn Feline Foundation announced funding in December for feline health studies on the following topics: the effects of antibiotics on microbiota, the efficacy of novel gastroprotectants, a novel hepadnavirus, identification of genes that cause disease, the effects of brachycephalic conformation on cardiopulmonary health, and evaluation of commercial diets for calcium and phosphorus.
In partnership with the George Sydney and Phyllis Redman Miller Trust, Winn announced grants for the following studies:
- "Metagenomic and metabolomic analysis of the short-term and long term effects of antibiotic therapy on the intestinal microbiota in growing kittens and their relation to the overall health status of these kittens," Dr. Jan Suchodolski, Texas A&M University, and Dr. Panagiotis Xenoulis, University of Thessaly, $34,800.
- "Evaluating the efficacy of novel gastroprotectants in cats," Drs. M. Katherine Tolbert and Adesola Odunayo, University of Tennessee, $18,080.
- "Estimating the significance of a novel feline hepadnavirus in hepatitis and liver cancer," Dr. Patricia Pesavento, University of California-Davis, $34,880.
- "Precision medicine genomics for cats," Leslie Lyons, PhD, University of Missouri-Columbia, $12,648, with an additional $21,651 from Winn.
- "The effects of brachycephalic conformation on cardiopulmonary health in cats," Drs. Heidi Phillips and Hadley Gleason, University of Illinois, $31,696.
Winn also announced a $9,103 grant through the Feline Kidney Disease Campaign for the study "Evaluation of commercial feline diets for calcium, phosphorous and the calcium to phosphorous ratio" by Dr. Jonathan Stockman at Colorado State University.